Improvement of tardive dyskinesia following switch from neuroleptics to olanzapine

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 26, Issue 4, 2002, Pages 815-817

  Lykouras, Lefteris ^a   Agelopoulos, Elias ^a   Tzavellas, Elias ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Olanzapine; Schizophrenia; Tardive dyskinesia

Indexed keywords

AMITRIPTYLINE; BIPERIDEN; CHLORPROMAZINE; DIAZEPAM; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; PENFLURIDOL; THIORIDAZINE; TRIFLUOPERAZINE; BENZODIAZEPINE DERIVATIVE; DRUG DERIVATIVE; PIRENZEPINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; HUMAN; MALE; MOTOR DYSFUNCTION; REMISSION; TARDIVE DYSKINESIA; TREATMENT OUTCOME; COMPARATIVE STUDY; DYSKINESIA; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADULT; ANTIPSYCHOTIC AGENTS; CASE REPORT; COMPARATIVE STUDY; DYSKINESIA, DRUG-INDUCED; HUMAN; MALE; MIDDLE AGE; PIRENZEPINE; BENZODIAZEPINES; HUMANS; MIDDLE AGED;

EID: 0036016299     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(01)00303-7     Document Type: Article

References (19)

1. Olanzapine for the treatment of tardive dyskinesia
2. Randomized double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol
3. Radioreceptor binding profile of the atypical antipsychotic olanzapine
4. Tardive dyskinesia, clozapine, and treatment response
5. Improvement of tardive dyskinesia in a bipolar patient with olanzapine
6. Withdrawal syndromes associated with antipsychotic drugs
7. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality
8. Remission of tardive dyskinesia after changing from flupethixol to olanzapine
9. 2 receptor occupancy of clozapine, risperidone, and olanzapine in Schizophrenia
10. Marked reduction of tardive dyskinesia following treatment with olanzapine
11. Marked improvement in tardive dyskinesia following treatment with olanzapine in an elderly patient
12. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding
13. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation
14. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia
15. Olanzapine in the treatment of tardive dyskinesia. A report of two cases
16. Dopamine receptors antagonist